Rocket Companies Interest Paid remained flat by 0.0% to $149.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 24.4%, from $119.75M to $149.00M. Over 4 years (FY 2021 to FY 2025), Interest Paid shows an upward trend with a 9.0% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
interest_paid| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | $422.59M | $321.18M | $379.00M | $479.00M | $596.00M |
| YoY Change | — | -24.0% | +18.0% | +26.4% | +24.4% |